Denali Therapeutics (DNLI) Shares Outstanding (Entity) (2017 - 2026)

Denali Therapeutics (DNLI) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Entity.) (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	253.35 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	139.80 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	62.54 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	214.24 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	113.02 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	575.47 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	133.73 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	218.28 Mn
10	Denali Therapeutics	3.90 Bn	3.90 Bn	3.51 Mn	159.76 Mn

Download Data